GENE ONLINE|News &
Opinion
Blog

Cas9
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
New Cas9 Alternatives Give Mammoth Biosciences an Edge Over Other CRISPR companies
2020-10-25
CRISPR Pioneers Bag 2020 Nobel Prize in Chemistry
2020-10-07
Scientists Further Powerful Gene Editing Tech’s Caliber with Rapid, Low Cost COVID-19 Diagnosis
2020-09-06
Spotlight: New Hypercompact Megaphage Cas Enzyme (CasΦ) Shows Efficient Gene Editing
2020-08-16
CRISPR C-to-G Base Editors: A Therapeutic Promise
2020-07-31
Verve Therapeutic’s One Time Base Editing Treatment Cuts Down Cholesterol Levels in Blood
2020-06-30
Evolved Cas9 Facilitates CRISPR Access to Previously Unexplored Genomic Sites
2020-03-31
Jennifer Doudna Cofounded Mammoth Biosciences Bags $45M for CRISPR Based Diagnostics
2020-02-01
Broad Institute and Cyrus Biotech Join Hands to Develop Safe CRISPR
2019-12-05
Ignavibacterium Cas9 Beats Thermostability Record, Functions at 100 Degree Celsius
2019-11-14
The CRISPR-Cas9 Report Card
2018-06-14
LATEST
Regeneron Steps In to Rescue 23andMe From Bankruptcy With $256M Acquisition
2025-05-20
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
2025-05-20
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
2025-05-19
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top